Marco Lombardo Selected Research

Marco Lombardo Research Topics

Disease

8	Myopia 03/2016 - 09/2004
6	Keratoconus 03/2022 - 01/2016
6	Astigmatism 09/2011 - 09/2006
4	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2018 - 09/2013
4	Cataract (Cataracts) 01/2017 - 01/2014
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2018 - 09/2013
3	Corneal Wavefront Aberration 11/2014 - 04/2006
3	Neoplasms (Cancer) 11/2010 - 05/2007
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2008 - 09/2002
2	Disease Progression 03/2022 - 08/2015
2	Corneal Diseases (Corneal Disease) 01/2018 - 03/2010
2	Retinal Diseases 01/2017 - 12/2012
2	Colonic Neoplasms (Colon Cancer) 01/2017 - 05/2014
2	Colorectal Neoplasms (Colorectal Cancer) 05/2007 - 03/2006
1	Overweight 01/2022
1	Pathologic Dilatation (Ectasia) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Leishmaniasis 11/2020
1	Neglected Diseases 11/2020
1	Epiretinal Membrane (Epiretinal Membranes) 01/2016
1	Calculi (Calculus) 08/2015
1	Coma (Comas) 02/2011
1	Capsule Opacification 07/2009
1	Fatigue 03/2006
1	Diarrhea 03/2006
1	Vomiting 03/2006
1	Ovarian Neoplasms (Ovarian Cancer) 10/2005
1	Neutropenia 02/2005
1	Febrile Neutropenia 02/2005
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2005
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2003
1	Anemia 04/2003
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2002

Drug/Important Bio-Agent (IBA)

6	Retinaldehyde (Retinal)IBA 11/2018 - 12/2012
2	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2022 - 01/2018
2	Pharmaceutical PreparationsIBA 11/2020 - 11/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 05/2014
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 08/2015
2	Interleukin-2 (IL2)IBA 05/2007 - 10/2005
2	Isotretinoin (Accutane)FDA LinkGeneric 05/2007 - 10/2005
2	Gemcitabine FDA Link 02/2005 - 03/2002
1	Fluconazole (Zonal)FDA LinkGeneric 03/2022
1	Carotenoids (Carotene)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2014
1	Glucose (Dextrose)FDA LinkGeneric 03/2014
1	4-hexyloxyaniline (HOA)IBA 02/2011
1	Biocompatible Materials (Biomaterials)IBA 07/2009
1	fludarabineIBA 03/2008
1	AnthracyclinesIBA 03/2006
1	Thymidylate SynthaseIBA 03/2006
1	Irinotecan (Camptosar)FDA LinkGeneric 03/2006
1	Uridine Diphosphate (UDP)IBA 03/2006
1	TransferasesIBA 03/2006
1	raltitrexed (D 1694)IBA 03/2006
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 03/2006
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2005
1	Etoposide (VP 16)FDA LinkGeneric 02/2005
1	Cisplatin (Platino)FDA LinkGeneric 02/2005
1	Epirubicin (Ellence)FDA LinkGeneric 04/2003
1	Chlorambucil (Leukeran)FDA Link 04/2003
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2002
1	Bleomycin (Blenoxane)FDA LinkGeneric 09/2002
1	Prednisone (Sone)FDA LinkGeneric 09/2002
1	Vincristine (Oncovin)FDA LinkGeneric 09/2002
1	Ifosfamide FDA LinkGeneric 03/2002
1	Vinorelbine (Navelbine)FDA LinkGeneric 03/2002

Therapy/Procedure

8	Photorefractive Keratectomy 09/2011 - 09/2004
6	Corneal Cross-Linking 01/2022 - 01/2016
4	Lasers (Laser) 01/2017 - 01/2014
4	Excimer Lasers 03/2016 - 09/2004
3	Corneal Transplantation (Keratoplasty) 01/2018 - 03/2010
3	Therapeutics 03/2008 - 10/2005
3	Drug Therapy (Chemotherapy) 05/2007 - 10/2005
1	Glycemic Control 11/2018
1	Laser Therapy (Surgery, Laser) 01/2018
1	Laser In Situ Keratomileusis (LASIK) 03/2016
1	Vitrectomy 01/2016
1	Multifocal Intraocular Lenses 01/2016
1	Phacoemulsification 11/2014
1	Aftercare (After-Treatment) 03/2008
1	Induction Chemotherapy 05/2007
1	Drug Tapering 02/2005
1	Treatment Delay 02/2005
1	CHOP-B protocol 09/2002